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**Abstract**

Patients with Schizophrenia respond differently to antipsychotic drug treatment. The underlying mechanism for these individuals' differences remains unknown. However, there is growing evidence indicating that genetic background contributes substantially to efficacy of antipsychotic drug. In order to test the genetic mechanism of treatment response of antipsychotic drugs, we performed exome sequencing in a group of patients with very good response and matched patients without response. And reduction rates of PANSS and sub-scales were used to evaluate treatment responses. We found that a number of genes (*ZNF804A*, *PIWIL4*, *TG* and *KALRN*) involved in treatment response of antipsychotic drug. Pathway analysis showed that pathways involved in glutamate, including the pathways involved in CNS and abnormal neurotransmitter level, and the N-methyl-D-aspartate (NMDA) andα-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) mediated synaptic pathways, were detected to implicate in treatment response of antipsychotic drugs. Especially, the treatment response for negative symptoms was more significantly associated with these two pathways.
